Related Experiment Video
Updated: Jan 18, 2026

10:20
Generation of a Human iPSC-Based Blood-Brain Barrier Chip
Published on: March 2, 2020
13.5K
Democratizing Organ-On-Chip Technologies With a Modular, Reusable, and Perfusion-Ready Microphysiological System
Daniel J Minahan1, Katherine M Nelson2, Filipa Ribeiro1
1Department of Biomedical Engineering, University of Delaware, Newark, DE, 19716, USA.
Advanced Healthcare Materials
|September 11, 2025
Summary
A new modular organ-on-chip platform simplifies microphysiological systems (MPS) fabrication and use. This adaptable system enhances reproducibility and accessibility for advanced in vitro model development.
Area of Science:
- Biotechnology
- Tissue Engineering
- Microfluidics
Background:
- Organ-on-chip (OOC) and microphysiological systems (MPS) offer dynamic cell culture but face adoption barriers due to complex fabrication, material limitations (e.g., polydimethylsiloxane), and poor modularity.
- Existing static cell culture methods lack the physiological relevance of dynamic microenvironments crucial for advanced in vitro modeling.
- Widespread use of OOC/MPS is limited by fabrication complexity, material constraints, and lack of modularity, hindering broader scientific adoption.
Purpose of the Study:
- To present a novel, modular microphysiological system (MPS) platform designed for ease of use, enhanced reproducibility, and broad applicability in organ-on-chip development.
- To decouple model establishment from perfusion experiments, streamlining workflows for researchers.
- To establish a generalizable framework for modular tissue-chip development adaptable to diverse organ systems.
Main Methods:
- Development of a modular MPS platform using layered elastomeric inserts for dual monolayer cell culture within a reusable acrylic cassette for perfusion.
- Validation using dual epithelial and endothelial cell co-culture under static and perfused conditions, including shear stress application.
- Utilizing vinyl cutting for reproducible manufacturing and material testing for biocompatibility assessment.
Main Results:
- The platform demonstrated high manufacturing fidelity and biocompatibility, supporting long-term cell culture (up to 14 days).
- Successful co-culture of epithelial and endothelial cells was achieved, with observed shear-induced alignment of HUVECs under perfusion.
- The modular design facilitated uniform cell seeding, imaging access, and parallelized experimentation with minimized pump usage.
Conclusions:
- The developed modular MPS platform overcomes key limitations of current OOC technologies, offering a user-friendly, reproducible, and versatile solution.
- This approach democratizes advanced in vitro model systems, making them accessible to labs lacking specialized microfabrication infrastructure.
- The platform serves as a foundational framework for developing diverse organ-specific tissue chips, advancing in vitro research.

